Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -594 Million EUR | -143.29% |
| 2022 | 1.37 Billion EUR | -24.53% |
| 2021 | 1.81 Billion EUR | 6.5% |
| 2020 | 1.7 Billion EUR | -9.35% |
| 2019 | 1.88 Billion EUR | -7.1% |
| 2018 | 2.02 Billion EUR | 11.74% |
| 2017 | 1.81 Billion EUR | 13.87% |
| 2016 | 1.59 Billion EUR | 17.3% |
| 2015 | 1.35 Billion EUR | 27.27% |
| 2014 | 1.06 Billion EUR | 5.54% |
| 2013 | 1.01 Billion EUR | 9.18% |
| 2012 | 926 Million EUR | -30.27% |
| 2011 | 1.32 Billion EUR | 10.21% |
| 2010 | 1.2 Billion EUR | 21.59% |
| 2009 | 991 Million EUR | 267.04% |
| 2008 | 270 Million EUR | -34.15% |
| 2007 | 410 Million EUR | 24.24% |
| 2006 | 330 Million EUR | 48.65% |
| 2005 | 222 Million EUR | 32.14% |
| 2004 | 168 Million EUR | 46.09% |
| 2003 | 115 Million EUR | -14.18% |
| 2002 | 134 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -373 Million EUR | -234.17% |
| 2024 Q1 | 278 Million EUR | 145.28% |
| 2023 Q4 | -614 Million EUR | -51.23% |
| 2023 FY | -594 Million EUR | -143.29% |
| 2023 Q1 | 346 Million EUR | 35.69% |
| 2023 Q2 | 80 Million EUR | -76.88% |
| 2023 Q3 | -406 Million EUR | -607.5% |
| 2022 Q3 | 321 Million EUR | -16.19% |
| 2022 Q4 | 255 Million EUR | -20.56% |
| 2022 FY | 1.37 Billion EUR | -24.53% |
| 2022 Q1 | 413 Million EUR | -17.23% |
| 2022 Q2 | 383 Million EUR | -7.26% |
| 2021 Q4 | 499 Million EUR | 20.82% |
| 2021 Q2 | 471 Million EUR | 8.28% |
| 2021 Q1 | 435 Million EUR | 6.1% |
| 2021 Q3 | 413 Million EUR | -12.31% |
| 2021 FY | 1.81 Billion EUR | 6.5% |
| 2020 Q4 | 410 Million EUR | -3.98% |
| 2020 Q1 | 459 Million EUR | -10.87% |
| 2020 Q2 | 411 Million EUR | -10.46% |
| 2020 Q3 | 427 Million EUR | 3.89% |
| 2020 FY | 1.7 Billion EUR | -9.35% |
| 2019 FY | 1.88 Billion EUR | -7.1% |
| 2019 Q1 | 453 Million EUR | -12.21% |
| 2019 Q4 | 515 Million EUR | 15.99% |
| 2019 Q3 | 444 Million EUR | -5.73% |
| 2019 Q2 | 471 Million EUR | 3.97% |
| 2018 Q3 | 419 Million EUR | -35.74% |
| 2018 Q4 | 516 Million EUR | 23.15% |
| 2018 FY | 2.02 Billion EUR | 11.74% |
| 2018 Q1 | 440 Million EUR | -13.89% |
| 2018 Q2 | 652 Million EUR | 48.18% |
| 2017 Q1 | 457 Million EUR | 4.1% |
| 2017 Q4 | 511 Million EUR | 29.04% |
| 2017 Q3 | 396 Million EUR | -12.0% |
| 2017 FY | 1.81 Billion EUR | 13.87% |
| 2017 Q2 | 450 Million EUR | -1.53% |
| 2016 Q4 | 439 Million EUR | 14.92% |
| 2016 Q2 | 378 Million EUR | 5.59% |
| 2016 Q1 | 358 Million EUR | -0.28% |
| 2016 FY | 1.59 Billion EUR | 17.3% |
| 2016 Q3 | 382 Million EUR | 1.06% |
| 2015 Q1 | 317 Million EUR | 23.35% |
| 2015 FY | 1.35 Billion EUR | 27.27% |
| 2015 Q4 | 359 Million EUR | 0.56% |
| 2015 Q3 | 357 Million EUR | 9.85% |
| 2015 Q2 | 325 Million EUR | 2.52% |
| 2014 FY | 1.06 Billion EUR | 5.54% |
| 2014 Q2 | 286 Million EUR | 15.32% |
| 2014 Q3 | 276 Million EUR | -3.5% |
| 2014 Q4 | 257 Million EUR | -6.88% |
| 2014 Q1 | 248 Million EUR | -12.68% |
| 2013 Q2 | 243 Million EUR | 10.96% |
| 2013 Q3 | 265 Million EUR | 9.05% |
| 2013 Q4 | 284 Million EUR | 7.17% |
| 2013 FY | 1.01 Billion EUR | 9.18% |
| 2013 Q1 | 219 Million EUR | -9.13% |
| 2012 Q4 | 241 Million EUR | -0.82% |
| 2012 FY | 926 Million EUR | -30.27% |
| 2012 Q2 | 407 Million EUR | -10.55% |
| 2012 Q1 | 455 Million EUR | 14.32% |
| 2012 Q3 | 243 Million EUR | -40.29% |
| 2011 Q3 | 393 Million EUR | 43.43% |
| 2011 Q4 | 398 Million EUR | 1.27% |
| 2011 FY | 1.32 Billion EUR | 10.21% |
| 2011 Q2 | 274 Million EUR | 4.18% |
| 2011 Q1 | 263 Million EUR | -24.64% |
| 2010 FY | 1.2 Billion EUR | 21.59% |
| 2010 Q4 | 349 Million EUR | 0.87% |
| 2010 Q2 | 300 Million EUR | 44.93% |
| 2010 Q1 | 207 Million EUR | -28.37% |
| 2010 Q3 | 346 Million EUR | 15.33% |
| 2009 Q3 | 188 Million EUR | -20.0% |
| 2009 Q2 | 235 Million EUR | -15.77% |
| 2009 Q1 | 279 Million EUR | 0.0% |
| 2009 FY | 991 Million EUR | 267.04% |
| 2009 Q4 | 289 Million EUR | 53.72% |
| 2008 FY | 270 Million EUR | -34.15% |
| 2007 FY | 410 Million EUR | 24.24% |
| 2006 FY | 330 Million EUR | 48.65% |
| 2005 FY | 222 Million EUR | 32.14% |
| 2004 FY | 168 Million EUR | 46.09% |
| 2003 FY | 115 Million EUR | -14.18% |
| 2002 FY | 134 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 498.99 Million EUR | 219.039% |
| LIMES Schlosskliniken AG | 3.39 Million EUR | 17588.658% |
| M1 Kliniken AG | 10.27 Million EUR | 5881.425% |
| Maternus-Kliniken Aktiengesellschaft | -14.25 Million EUR | -4066.374% |
| MEDICLIN Aktiengesellschaft | -10.77 Million EUR | -5412.187% |
| RHÖN-KLINIKUM Aktiengesellschaft | 38.71 Million EUR | 1634.408% |
| VITA 34 AG | -1.86 Million EUR | -31749.866% |